Navigation Links
OncoSec Medical Reports Positive Interim Efficacy Results from Phase IV Study of NeoPulse in Skin Cancer Patients
Date:11/14/2012

SAN DIEGO, Nov. 14, 2012 /PRNewswire/ -- OncoSec Medical Inc. (OTCBB: ONCS), a company developing its advanced-stage ImmunoPulse DNA-based immunotherapy and NeoPulse therapy to treat solid tumors, announced positive interim results from a Phase IV trial investigating the use of NeoPulse in skin cancer patients at the 6th World Meeting of Interdisciplinary Melanoma/Skin Care Centres & 8th EADO Congress. Data from the trial showed a complete response of greater than 90 percent in basal cell carcinoma patients and 70 percent in squamous cell carcinoma patients at six months.

(Logo: http://photos.prnewswire.com/prnh/20120905/LA68078LOGO)

The data was presented in a poster titled "Interim analysis of an open-labeled, single-arm multicenter study of electrochemotherapy in skin cancer" by lead author Paul Goldfarb, M.D., and coauthors Lennart Lofgren, M.D., Ph.D., Axel Hauschild, M.D. and Richard Heller, Ph.D.

Dr. Hauschild said, "Based on these interim results, NeoPulse appears to provide local control with the potential advantage of preserving normal tissue, and therefore warrants further exploration as an alternative or even adjuvant treatment in cutaneous skin cancers." Dr. Hauschild is a dermato-oncologist and professor of dermatology at the University of Kiel, Germany, and faculty member of the 6th World Meeting of Interdisciplinary Melanoma/Skin Care Centres & 8th EADO Congress.

The primary goal of this phase IV cutaneous cancer study was to assess the ability of NeoPulse to control growth or recurrence of the cancer six months following treatment, equivalent to surgery as compared to historical controls, with respect to primary (new) tumors and locally recurrent tumors. The study was conducted at 15 clinical centers across Western Europe. A total of 88 patients were enrolled and received treatment. At the time of analysis, 69 of 88 (78.4 percent) patients we
'/>"/>

SOURCE OncoSec Medical Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. OncoSec to Present at Upcoming Healthcare and Investor Conferences
2. OncoSec Granted New Patent from China
3. OncoSec to Present at the Rodman & Renshaw 2012 Annual Global Investment Conference
4. OncoSec Featured on KTVU-TV News and in San Francisco Chronicle
5. OncoSec OMS ElectroChemotherapy for Head and Neck Cancer Shows Enhanced Quality of Life in Two Randomized Phase III Studies
6. OncoSec Establishes Clinical Site for Its Phase II Merkel Cell Carcinoma Trial at University of California San Francisco (UCSF)
7. OncoSec Presents Preliminary Safety Data for Phase II Melanoma Study at Second European Post-Chicago Melanoma Meeting 2012
8. OncoSec Medical Issues Letter to Shareholders
9. OncoSec ElectroChemotherapy Demonstrates Potential as Alternative to Surgery for Treating Head and Neck Cancer
10. Filtrona Porous Technologies Introduces New Medical-Grade Foams And Unique Fiber Products For Clean Environments At MEDICA / COMPAMED Trade Fair
11. Rochester Medical Reports Record Fourth Quarter and Fiscal Year Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... ALBANY, New York , July 28, 2015 ... of a new report, titled " Cancer Diagnostics ... Forecast, 2014 - 2020 " . According to this ... at a CAGR of 7.6% during the forecast period of ... was valued at US$100,994.5 million and is expected to be ...
(Date:7/28/2015)... -- Mike Rowe , spokesperson and reality television personality, ... 2015 ThoughtSpot conference and tradeshow, which runs ... Vegas, Nev. Best known for ... Discovery Channel,s, "Dirty Jobs," Mr. Rowe spent a decade traveling ... people whose hard work, sacrifice and value aren,t always recognized. ...
(Date:7/28/2015)... ROCHESTER, N.Y. , July 28, 2015 ... of clinical trial imaging solutions, today announced that it ... the 4:00 p.m. ET market close on Tuesday, August ... chief executive officer, and Jim Groff , chief ... to discuss the company,s financial results and provide a ...
Breaking Medicine Technology:Cancer Diagnostics Market is Expected to Grow at CAGR of 7.6% From 2014 to 2020, to be Worth US$168,649.3 Million by 2020: Transparency Market Research 2Cancer Diagnostics Market is Expected to Grow at CAGR of 7.6% From 2014 to 2020, to be Worth US$168,649.3 Million by 2020: Transparency Market Research 3Cancer Diagnostics Market is Expected to Grow at CAGR of 7.6% From 2014 to 2020, to be Worth US$168,649.3 Million by 2020: Transparency Market Research 4Mike Rowe to Address Community Pharmacists at ThoughtSpot 2015 2VirtualScopics, Inc. Schedules Second Quarter 2015 Financial Results Press Release, Conference Call And Webcast 2VirtualScopics, Inc. Schedules Second Quarter 2015 Financial Results Press Release, Conference Call And Webcast 3
... Even with a steadily improving economy, 130,000 children and families ... meet. This spring, Shire Pharmaceuticals is issuing a "call to action" for ... regional donation drive to benefit Cradles to Crayons. , ... Most Cradles to Crayons recipients have incomes ...
... LOVELAND, Colo. , May 10 Heska Corporation (Nasdaq: HSKA ... Conference on Wednesday, May 12, 2010 .  The presentation will be at The ... City and is scheduled to begin at 9:55 a.m. Eastern Time . ... (Logo:   http://www.newscom.com/cgi-bin/prnh/20000622/HESKALOGO ) , ...
Cached Medicine Technology:Area Residents Can Give a Little, Help A Lot at Shire's BIG GIVE 2
(Date:7/28/2015)... (PRWEB) , ... July 28, 2015 , ... Santa Rosa’s The Press Democrat announced its ... a row, Dr. Francisco Canales and Dr. Heather Furnas took the top spot as the ... Dr. Furnas and Dr. Canales are proud to be bestowed such a prestigious title. ...
(Date:7/28/2015)... ... July 28, 2015 , ... World Patent Marketing, ... new household invention that makes shelling eggs an exact science. , “The global ... Cooper, CEO and Creative Director of World Patent Marketing. “With a growth rate ...
(Date:7/28/2015)... ... July 28, 2015 , ... The Denver ... of Philanthropy Reframed and Exhibited,” a photographic and narrative exploration of African American ... historic Five Points neighborhood. , Denver is one of only ten cities to ...
(Date:7/28/2015)... ... 28, 2015 , ... Autism is the fastest growing serious ... with the disorder. For these families, identifying and paying for the help they ... That’s where Talk About Curing Autism (TACA), a national non-profit organization dedicated to ...
(Date:7/28/2015)... FL (PRWEB) , ... July 16, 2015 (PRWEB) ... ... Insurance Agency, in Miami, FL, that specializes in providing Health insurance quotes to ... multiple carriers clients compare auto insurance rates that best suits their specific needs. ...
Breaking Medicine News(10 mins):Health News:Dr. Canales and Dr. Furnas Honored as Sonoma County’s Best Cosmetic Surgeons 2Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 2Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 3Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 4Health News:Essential Bang For Your Buck Kitchen Items Presented By World Patent Marketing 5Health News:"The Soul of Philanthropy Reframed and Exhibited” Comes to Denver 2Health News:National TACA Autism Conference Offers Hope and Help to Families Affected by Autism 2Health News:Nations Insurance Solutions Announces Auto, Motorcycle, and Commercial Business Insurance Quotes. 2
... FRANCISCO, Feb. 19 California attorneys and a,presiding judge ... notables,that will assemble next month in Los Angeles to ... , Robert Berkes of Berkes ... an,insurer,s perspective on asbestos litigation; Steven Kazan of Kazan ...
... WINNIPEG, Feb. 19 /PRNewswire-FirstCall/ - IMRIS Inc. (TSX: ... five-year research initiative to focus on the development ... procedures, working with the University Health Network (UHN) ... of IMRIS into the field of image guided ...
... Champion for BabiesNEW YORK, Feb. 19 The March of Dimes ... MVP, Eli Manning , will return for a second year, to ... will be joined by CBS 2 News Co-Anchor, Maurice DuBois ... who will co-host the morning program. "I,m very excited to be ...
... linked to risk-taking, too, study finds, , , THURSDAY, ... that makes people love skydiving, mountain-climbing or other ... of the brain that has been linked to ... University researchers studied volunteers who were grouped as ...
... transplanting stem cells from the patient,s own bone marrow is an ... , The procedure has been tested successfully in the US ... in 80% of cases, and considerable improvement in quality of life ... has used this therapy in a total of 6 patients. ...
... Children,s Hospital and Salvation Army Receive Top Awards In January; ... the Fight Against Breast Cancer and Wounded WarriorsWHITE PLAINS, N.Y., ... for change appear to have extended all the way to ... on to IWON.com last month to play games on behalf ...
Cached Medicine News:Health News:California Attorneys Featured at Major Asbestos Litigation Event 2Health News:IMRIS announces development program for MR guided radiation and interventional applications 2Health News:Eli Manning to Lead March for Babies(R) in Manhattan 2Health News:Thrill-Seekers' Brains May Be Wired Differently 2Health News:New therapy with stem cells to treat Crohn's disease 2Health News:New therapy with stem cells to treat Crohn's disease 3Health News:New therapy with stem cells to treat Crohn's disease 4Health News:New therapy with stem cells to treat Crohn's disease 5Health News:Casual Gamers Join Forces With Top Charities to Compete for IWON.com Cash Prizes 2Health News:Casual Gamers Join Forces With Top Charities to Compete for IWON.com Cash Prizes 3
... first identified in 1980 (1) and has only ... appetite (2). PYY is produced by the gut ... and is found to decrease appetite. The main ... circulation is PYY3-36, the N-terminal truncated form of ...
... is the glucuronide conjugate of 3alpha-androstanediol, ... [1,2]. 3alpha-diol G has strong androgenic ... bioactivity of testosterone [2]. Serum 3alpha-diol ... reduction of DHT, and in addition, ...
... as bone Gla protein, is a vitamin ... major component of the noncollagenous bone matrix ... bone, with a small amount produced by ... During bone formation, newly synthesized osteocalcin is ...
... growth factor binding protein 4 (IGFBP-4) is a ... the actions of IGF-I and IGF-II. It is ... molecular weight of 28 kDa. IGFBP-4 has been ... in numerous cell types, including fibroblasts, neuroblastoma, prostate ...
Medicine Products: